BRAF mutations in non-Hodgkin's lymphoma
Author Information
Author(s): Lee J W, Yoo N J, Soung Y H, Kim H S, Park W S, Kim S Y, Lee J H, Park J Y, Cho Y G, Kim C J, Ko Y H, Kim S H, Nam S W, Lee J Y, Lee S H
Primary Institution: Department of Pathology, College of Medicine, The Catholic University of Korea
Hypothesis
The study investigates the occurrence of BRAF gene mutations in non-Hodgkin's lymphoma (NHL).
Conclusion
BRAF gene mutations were found in a small percentage of diffuse large B-cell lymphomas, suggesting a potential role in NHL carcinogenesis.
Supporting Evidence
- BRAF mutations were detected in 2.4% of the NHL samples analyzed.
- All identified BRAF mutations were found in diffuse large B-cell lymphomas.
- Three of the four mutations involved the same amino acid in the BRAF gene.
Takeaway
The researchers looked at cancer samples from 164 patients and found some had changes in a gene called BRAF, which might help us understand how this type of cancer grows.
Methodology
The study used paraffin-embedded tissues from patients, performed microdissection to obtain tumor cells, and analyzed BRAF mutations through PCR and sequencing.
Limitations
The study only identified BRAF mutations in diffuse large B-cell lymphomas and did not explore other types of NHL.
Participant Demographics
Patients with non-Hodgkin's lymphoma, specific types not detailed.
Statistical Information
Statistical Significance
p>0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website